NAGIOS: RODERIC FUNCIONANDO

Low-level laser therapy in patients with Burning Mouth Syndrome : a double-blind, randomized, controlled clinical trial

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Low-level laser therapy in patients with Burning Mouth Syndrome : a double-blind, randomized, controlled clinical trial

Mostra el registre parcial de l'element

dc.contributor.author Cassol-Spanemberg, Juliana es
dc.contributor.author Segura-Egea, Juan J. es
dc.contributor.author Rodríguez de Rivera Campillo, M. E. es
dc.contributor.author Jane Salas, Enric es
dc.contributor.author Salum, Fernanda-Gonçalves es
dc.contributor.author López López, José es
dc.date.accessioned 2019-04-01T12:02:12Z
dc.date.available 2019-04-01T12:02:12Z
dc.date.issued 2019 es
dc.identifier.citation Cassol-Spanemberg, Juliana ; Segura-Egea, Juan J. ; Rodríguez de Rivera Campillo, M. E. ; Jane Salas, Enric ; Salum, Fernanda-Gonçalves ; López López, José. Low-level laser therapy in patients with Burning Mouth Syndrome : a double-blind, randomized, controlled clinical trial. En: Journal of Clinical and Experimental Dentistry, 11 2 2019: 162-169 es
dc.identifier.uri http://hdl.handle.net/10550/69682
dc.description.abstract Evaluate the effect of LLLT in the treatment of burning mouth syndrome (BMS). Twenty-one BMS patients were randomly assigned to two groups: 12 in the laser group (LG) and 9 in the control group (CG). Patients in the LG underwent 2-week sessions of LLLT for 4 weeks. The spot tip area of this tool is 0.088cm2, semi-conductor GaAlAs, with a wavelength of 808nm ±5nm (infrared), 200 mW output power, 1.97W/cm2 of power density, 3 J energy per point and application time 15 seconds per point. LLLT was applied punctually, in continuous emissions, on each of the sites where there was a symptom. Symptoms were evaluated with a visual analogue scale (VAS) and patient psychological profiles were assessed using the Hospital Anxiety-Depression Scale. No side effects were recorded. Statistical analysis was carried out via ANOVA and logistic regression analysis. The initial VAS score mean was 8.9 for the LG and 8.3 for the CG (p >0.05). After the eighth session the VAS score was 5.5 and 5.8 respectively, and at two months it was 4.7 and 5.1 respectively. Improvement variables were established by dichotomizing the pain scales. We obtained levels of significance for the improvement variable for the LG at the two-month follow-up (p=0.0038) and for the univariate analysis of the treatment. The improvement was marginally significant in the multivariant analysis of: dry mouth, dysgeusia, pain and the treatment (p=0.0538). LLLT may be an alternative treatment for the relief of oral burning in patients with BMS. es
dc.title Low-level laser therapy in patients with Burning Mouth Syndrome : a double-blind, randomized, controlled clinical trial es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/jced.55517 es
dc.type.hasVersion VoR es_ES

Visualització       (652.1Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques